Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes

NCT00537303 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin detemir
DRUG: insulin aspart
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S